Cargando…

A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class

BACKGROUND: Cholesterol management drugs known as statins are widely used and often well tolerated; however, a variety of muscle-related side effects can arise. These adverse events (AEs) can have serious impact, and form a significant barrier to therapy adherence. Surveillance of post-marketing AEs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffman, Keith B., Kraus, Christina, Dimbil, Mo, Golomb, Beatrice A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425581/ https://www.ncbi.nlm.nih.gov/pubmed/22936996 http://dx.doi.org/10.1371/journal.pone.0042866

Ejemplares similares

OA12.01. Analysis of FDA mandated dietary supplement adverse event reports (AER) 2008-2009
por: Hardy, M, et al.
Publicado: (2012)

Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS
por: Kadoyama, Kaori, et al.
Publicado: (2011)

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project
por: de Bie, Sandra, et al.
Publicado: (2015)

Pneumothorax as an Adverse Drug Event: An Exploratory Aggregate Analysis of the US FDA AERS Database Including a Confounding by Indication Analysis Inspired by Cornfield's Condition
por: Hauben, Manfred, et al.
Publicado: (2013)

Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
por: Tamura, Takao, et al.
Publicado: (2012)

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
por: Kadoyama, Kaori, et al.
Publicado: (2011)

Unitised equipment at AERE
por: Kandiah, K
Publicado: (1958)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS)
por: Hoffman, Keith B., et al.
Publicado: (2014)

Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
por: Jiao, Xue-feng, et al.
Publicado: (2020)

The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
por: Hoffman, Keith B., et al.
Publicado: (2014)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019)

Erratum to: The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
por: Hoffman, Keith B., et al.
Publicado: (2014)

Accelerator studies at A.E.R.E., Harwell
por: Dunn, P D, et al.
Publicado: (1956)

Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
por: Lao, Dong-Hui, et al.
Publicado: (2021)

Aer Receptors Influence the Pseudomonas chlororaphis PCL1606 Lifestyle
por: Arrebola, Eva, et al.
Publicado: (2020)

A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes
por: Hoffman, Keith B., et al.
Publicado: (2015)

Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data
por: Nevin, Remington L., et al.
Publicado: (2017)

Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series
por: Cham, Stephanie, et al.
Publicado: (2015)

Physicians’ Experiences as Patients with Statin Side Effects: A Case Series
por: Koslik, Hayley J., et al.
Publicado: (2017)

In memory of two departed AER editors: Hilmi Hijazi and Mahmoud Keilani
por: Badran, Izdiad
Publicado: (2010)

In memory of departed editor of AER Burhan Adeen Alabed (1922-2014)
por: Takrouri, Mohamad Said Maani, et al.
Publicado: (2015)

Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database
por: Lehrer, Steven, et al.
Publicado: (2018)

Reporter’s occupation and source of adverse device event reports contained in the FDA’s MAUDE database
por: Kavanagh, Kevin T, et al.
Publicado: (2019)

Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
por: Iarikov, Dmitri, et al.
Publicado: (2015)

Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
por: Zhou, Jianxing, et al.
Publicado: (2022)

Analysis of reported adverse events of pipeline stents for intracranial aneurysms using the FDA MAUDE database
por: Porwal, Mokshal H., et al.
Publicado: (2023)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
por: Wu, Yan, et al.
Publicado: (2023)

Clostridium difficile Infection Risk with Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System
por: Teng, Chengwen, et al.
Publicado: (2019)

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database
por: Poluzzi, Elisabetta, et al.
Publicado: (2013)

Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
por: Picaut, Philippe
Publicado: (2018)

IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data
por: Legehar, Ashenafi, et al.
Publicado: (2016)

Adverse Events in Total Ankle Arthroplasty, Analysis of the FDA Medical and User Facility Device Experience Database
por: Mahmoud, Karim, et al.
Publicado: (2019)

Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database
por: Kan, Yusuke, et al.
Publicado: (2021)

Nouvelles du Centre Aéré de l’Association du Personnel du CERN
por: Jardin d'enfants
Publicado: (2015)

Differing isoforms of the cobalamin binding photoreceptor AerR oppositely regulate photosystem expression
por: Yamamoto, Haruki, et al.
Publicado: (2018)

DrivAER: Identification of driving transcriptional programs in single-cell RNA sequencing data
por: Simon, Lukas M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rui8mblou6tv6mi54b9mu2ojcc